Compare HCA Health Inc (HCA) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Microchip Technology Inc. — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Microchip Technology Inc. trades at $82.74 (market cap $43.72B). The key difference: HCA Health Inc is the larger of the two by market cap, and Microchip Technology Inc. pays the higher dividend (2.26%). Which is the better fit depends on your goals.
| HCA | MCHP | |
|---|---|---|
Market Cap | $82.17B | $43.72B |
Sector | Health | Technology |
52-Week High | $545.13 | $102.97 |
52-Week Low | $334.32 | $49.02 |
Enterprise Value | $131.08B | $49.01B |
Dividend Yield | 0.84% | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
Microchip Technology (MCHP) trades at $83.38, up 2.99% on the day, with a bearish technical signal but strong analyst support. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 expected at $0.70 EPS. Revenue for 2025 was $4.40B, though net income was slightly negative. The consensus price target is $112.75, implying significant upside. Recent news highlights AI and industrial IoT growth drivers, including new product launches in power-over-Ethernet and machine learning tools.
MCHP presents a mixed outlook: high valuation ratios (P/E 365.95, P/S 9.31) signal premium pricing, but robust analyst buy ratings (68.18%) and a history of earnings beats support optimism. Key risks include intense semiconductor competition, cyclical demand swings, and high debt levels. Investors should weigh the potential for AI-driven growth against margin pressures and macroeconomic headwinds affecting the chip sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
